These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 37341301)
1. ANO1-Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer-Associated Fibroblasts. Jiang F; Jia K; Chen Y; Ji C; Chong X; Li Z; Zhao F; Bai Y; Ge S; Gao J; Zhang X; Li J; Shen L; Zhang C Adv Sci (Weinh); 2023 Aug; 10(24):e2300881. PubMed ID: 37341301 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of Ca Liu Z; Zhang S; Hou F; Zhang C; Gao J; Wang K Int J Cancer; 2019 May; 144(9):2215-2226. PubMed ID: 30243029 [TBL] [Abstract][Full Text] [Related]
3. The Mechanistic Role of the Calcium-Activated Chloride Channel ANO1 in Tumor Growth and Signaling. Bill A; Alex Gaither L Adv Exp Med Biol; 2017; 966():1-14. PubMed ID: 28293832 [TBL] [Abstract][Full Text] [Related]
4. Role of ANO1 in tumors and tumor immunity. Li H; Yu Z; Wang H; Wang N; Sun X; Yang S; Hua X; Liu Z J Cancer Res Clin Oncol; 2022 Aug; 148(8):2045-2068. PubMed ID: 35471604 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells. Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553 [TBL] [Abstract][Full Text] [Related]
6. High ANO1 expression is a prognostic factor and correlated with an immunosuppressive tumor microenvironment in pancreatic cancer. Zhang G; Shu Z; Yu J; Li J; Yi P; Wu B; Deng D; Yan S; Li Y; Ren D; Hou Y; Lan C Front Immunol; 2024; 15():1341209. PubMed ID: 38352864 [TBL] [Abstract][Full Text] [Related]
7. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling. Britschgi A; Bill A; Brinkhaus H; Rothwell C; Clay I; Duss S; Rebhan M; Raman P; Guy CT; Wetzel K; George E; Popa MO; Lilley S; Choudhury H; Gosling M; Wang L; Fitzgerald S; Borawski J; Baffoe J; Labow M; Gaither LA; Bentires-Alj M Proc Natl Acad Sci U S A; 2013 Mar; 110(11):E1026-34. PubMed ID: 23431153 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of calcium-activated chloride channel ANO1 suppresses proliferation and induces apoptosis of epithelium originated cancer cells. Guan L; Song Y; Gao J; Gao J; Wang K Oncotarget; 2016 Nov; 7(48):78619-78630. PubMed ID: 27732935 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of microRNA-9 reduces inflammatory response and fibroblast proliferation in mice with idiopathic pulmonary fibrosis through the ANO1-mediated TGF-β-Smad3 pathway. Dai WJ; Qiu J; Sun J; Ma CL; Huang N; Jiang Y; Zeng J; Ren BC; Li WC; Li YH J Cell Physiol; 2019 Mar; 234(3):2552-2565. PubMed ID: 30144053 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of ANO1/TMEM16A induces apoptosis in human prostate carcinoma cells by activating TNF-α signaling. Song Y; Gao J; Guan L; Chen X; Gao J; Wang K Cell Death Dis; 2018 Jun; 9(6):703. PubMed ID: 29899325 [TBL] [Abstract][Full Text] [Related]
11. Involvement of TMEM16A/ANO1 upregulation in the oncogenesis of colorectal cancer. Yan Y; Ding X; Han C; Gao J; Liu Z; Liu Y; Wang K Biochim Biophys Acta Mol Basis Dis; 2022 Jun; 1868(6):166370. PubMed ID: 35231545 [TBL] [Abstract][Full Text] [Related]
12. ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis. Deng CM; Zhang GG; Liu QW; Xu JJ; Liu ZC; Yang J; Xu TY; Li ZG; Zhang F; Li B Cancer Res; 2023 Jun; 83(11):1851-1865. PubMed ID: 36912612 [TBL] [Abstract][Full Text] [Related]
13. LXR Signaling-Mediated Cholesterol Metabolism Reprogramming Regulates Cancer Cell Metastasis. Singh PK; Mehla K Cancer Res; 2023 Jun; 83(11):1759-1761. PubMed ID: 37264829 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of ANO1 expression in cancers. Zhang C; Li H; Gao J; Cui X; Yang S; Liu Z Medicine (Baltimore); 2021 Jan; 100(4):e24525. PubMed ID: 33530281 [TBL] [Abstract][Full Text] [Related]
15. Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer. Wang X; Zhou L; Wang H; Chen W; Jiang L; Ming G; Wang J Cancer Med; 2023 Nov; 12(21):20573-20589. PubMed ID: 37860928 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑144 suppresses aggressive phenotypes of tumor cells by targeting ANO1 in colorectal cancer. Jiang Y; Cai Y; Shao W; Li F; Guan Z; Zhou Y; Tang C; Feng S Oncol Rep; 2019 Apr; 41(4):2361-2370. PubMed ID: 30816505 [TBL] [Abstract][Full Text] [Related]
17. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer. Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728 [TBL] [Abstract][Full Text] [Related]
18. Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer. Liu L; Mo M; Chen X; Chao D; Zhang Y; Chen X; Wang Y; Zhang N; He N; Yuan X; Chen H; Yang J J Exp Clin Cancer Res; 2023 Apr; 42(1):85. PubMed ID: 37055842 [TBL] [Abstract][Full Text] [Related]
19. ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer. Bill A; Gutierrez A; Kulkarni S; Kemp C; Bonenfant D; Voshol H; Duvvuri U; Gaither LA Oncotarget; 2015 Apr; 6(11):9173-88. PubMed ID: 25823819 [TBL] [Abstract][Full Text] [Related]
20. Suppression of 14-3-3γ-mediated surface expression of ANO1 inhibits cancer progression of glioblastoma cells. Lee YS; Lee JK; Bae Y; Lee BS; Kim E; Cho CH; Ryoo K; Yoo J; Kim CH; Yi GS; Lee SG; Lee CJ; Kang SS; Hwang EM; Park JY Sci Rep; 2016 May; 6():26413. PubMed ID: 27212225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]